Medical education has not kept up with genetic discoveries — primary care physicians require more genetics and genomics training.
Academic rigor, journalistic flair
Articles on Precision medicine
Displaying 1 - 20 of 38 articles
Precision medicine is often touted as the future of medicine. But so far, it hasn't been helpful in the war against COVID-19. Here is how it could be used to tease apart the nuances of the disease.
PODCAST: The first episode of a new series from The Anthill focuses on precision medicine.
Introducing a new series from The Anthill podcast on the future of personalisation in healthcare.
Precision medicine is all the rage, but it may only be effective at treating less common diseases.
The first personalised medicine trial for a nutritional supplement has just reported its results.
Clinical trials are used to establish that medicines work. But these don't take into account the genetic differences between us that can mean very different outcomes for different patients.
Superfast DNA analysis is now being used to crack medical mysteries when physicians can't figure out whether an infectious microbe is causing the disease.
In an era of rapid technological advance, devastating climate change, increasing inequality and a steadily aging society, health-care leadership development is vital.
Asthma affects around 339 million people worldwide. A new drug promises to lower risks of asthma attack and may eventually allow patients to reduce their dependence on steroids.
"Precision medicine" is allowing us to analyse a person's genetic makeup and target treatments based on their specific needs.
It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
Precisely calibrated timekeepers are found in organisms from all domains of life. Biologists are studying how they influence plant/pathogen interactions – what they learn could lead to human medicines.
If you could take a test that would reveal the diseases you and your family might be more likely to get, would you want to do it?
People with the same condition can respond differently to the same treatment. This is why personalised treatment is so important in all fields of medicine, including psychology.
A test of all your genes for disease risk is not yet the precision diagnostic and treatment tool we hope it will one day be.
Cancer researchers dream of offering personalized treatments to patients. Can they get there using the same math that drives Netflix recommendations?
A field called epigenomics looks at chemical modifications that do not change our DNA sequence but can affect gene activity. What are the limitations, and can biomedicine use this to our advantage?
Top contributors
-
Professor and Regius Chair of Surgery, Director of Translational Research Centre, University of Glasgow
-
Research Investigator, Obstetrics and Gynecology, University of Michigan
-
Professor of Medicine, University of Oxford
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Honorary Fellow, Department of Pathology, The University of Melbourne
-
Director, Health Program, Grattan Institute
-
Deputy Vice-Chancellor Academic and Professor of Molecular Biology, UNSW
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Genetics and Executive Director of Research, Melbourne Health
-
Professor, The University of Queensland
-
Lorenzo and Pamela Galli Chair in Developmental Medicine, Murdoch Children's Research Institute
-
Muirhead Chair of Medicine and Director of Institute of Infection, Immunity and Inflammation, University of Glasgow
-
Associate Professor of Public Policy and Women's Studies, University of Michigan
-
Scientific Director of the Kidscan Childrens Cancer Research Charity, University of Salford
-
Professor of Environmental Health Sciences, Johns Hopkins University
